| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | See Remarks | SVP & Chief Financial Officer +1 more
3 companies
David D O'Toole is CFO at RCEL, with reported holdings spanning 3 companies. From March 2015 to June 2026, the filings on record show 26 open-market purchases and 0 sales. David D O'Toole's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.9M at current prices.
Our model assigns David D O'Toole a middling insider score of 51/100, based on 19 past trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -14.0%.
David D O'Toole's largest disclosed position is in RCEL as CFO, worth about $2.3M. Net of sales, the RCEL filings show accumulation of 31,675 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2016 | SLNO Soleno Therapeutics Inc | See Remarks | Buy | 10,000 | $0.92 | $9,238.00 | +30.5% | |
| May 12, 2016 | SLNO Soleno Therapeutics Inc | See Remarks | Buy | 5,000 | $1.16 | $5,775.00 | +18.0% | |
| Nov 17, 2015 | SLNO Soleno Therapeutics Inc | SVP & Chief Financial Officer | Buy | 5,000 | $1.79 | $8,950.00 | +22.0% | |
| Sep 14, 2015 | SLNO Soleno Therapeutics Inc | SVP & Chief Financial Officer | Buy | 7,500 | $2.38 | $17,885.25 | +49.2% | |
| Aug 11, 2015 | SLNO Soleno Therapeutics Inc | See Remarks | Buy | 10,000 | $1.78 | $17,800.00 | +190.5% | |
| Mar 13, 2015 | SLNO Soleno Therapeutics Inc | Chief Financial Officer | Buy | 5,250 | $6.23 | $32,707.50 | New |